Healthcare Disparities in Atopic Dermatitis in Latin America: A Narrative Review

ABSTRACT: Introduction: Atopic dermatitis (AD) is a chronic, pruritic skin disease caused by a mixture of genetic, immunological, and environmental factors, characterized by periods of inflammation and remission. In Latin America (LA), the prevalence of AD ranges up to 25% in children and 1-3% in ad...

Full description

Autores:
Sánchez Caraballo, Jorge Mario
Selva Ale, Iris
Valeria Angles, Maria
Guidos Fogelbach, Guillermo
Jansen, Angela Marie
Takaoka, Roberto
Borzutzky, Arturo
Tipo de recurso:
Review article
Fecha de publicación:
2023
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/45159
Acceso en línea:
https://hdl.handle.net/10495/45159
Palabra clave:
Dermatitis Atópica
Dermatitis, Atopic
Eccema
Eczema
América Latina
Latin America
Disparidades en Atención de Salud
Healthcare Disparities
Enfermedades de la Piel
Skin Diseases
Calidad de Vida
Quality of Life
https://id.nlm.nih.gov/mesh/D003876
https://id.nlm.nih.gov/mesh/D004485
https://id.nlm.nih.gov/mesh/D007843
https://id.nlm.nih.gov/mesh/D054625
https://id.nlm.nih.gov/mesh/D012871
https://id.nlm.nih.gov/mesh/D011788
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc/2.5/co/
Description
Summary:ABSTRACT: Introduction: Atopic dermatitis (AD) is a chronic, pruritic skin disease caused by a mixture of genetic, immunological, and environmental factors, characterized by periods of inflammation and remission. In Latin America (LA), the prevalence of AD ranges up to 25% in children and 1-3% in adults. The natural history of the disease for most patients is that AD goes into remission in adolescence and adult life. Only 10-30% of patients continue to have symptoms of the disease in adulthood. There are patients (3-4%) who have the onset of AD during adolescence or after adulthood. Those with limited access to healthcare services, such as diagnosis and treatment, have increased difficulties coping with AD. Healthcare disparities are a complex topic that include social, political, racial/ethnic, and geographical factors. Publications about healthcare disparities in AD in LA are scarce. As a result, recognizing and resolving healthcare inequalities is critical to improving the treatment and quality of life (QoL) of individuals with AD. Methods: A panel of Latin American experts in dermatology and allergies was provided with a series of relevant questions to address before a multiday conference. During this conference, the entire group discussed and edited each narrative through numerous drafts and rounds of discussion until they reached a consensus. Results: This paper examines the barriers to equal access to care and recommends realistic actions to overcome them. Inadequate disease knowledge, cultural and linguistic barriers, stigmatization, maldistribution of resources, absence of local clinical practice guidelines, arduous patient journey, and limited consultation time were identified as causes of health inequality. Conclusions: Among the suggested solutions are enhanced education for healthcare professionals, patients, and the general public, a focus on underprivileged communities, telemedicine and telementoring, translators, multidisciplinary teams, and local living clinical practice guidelines. Keywords: Atopic dermatitis; Eczema in Latin America; Healthcare disparities in Latin America; Latin America; Latin America skin disease treatment options; Quality of life for people with atopic dermatitis.